MALIGNANCY AND MORTALITY OF COLORECTAL POLYPS

Authors

  • Marilena STOIAN Carol Davila University of Medicine Bucharest, Romania
  • Nicoleta STATE Dr. Ion Cantacuzino Hospital, Bucharest, Romania
  • Emilia RUSU Carol Davila University of Medicine Bucharest, Romania
  • V. STOICA Carol Davila University of Medicine Bucharest, Romania
  • R. S. GAVRIL University of Medicine and Pharmacy ”Grigore T. Popa”- Iasi
  • Andreea GHERASIM
  • Gabriela RADULIAN Carol Davila University of Medicine Bucharest, Romania

Abstract

Objectives: To evaluate the rate of morbidity and mortality associated with colorectal polyps after the next 8-years period of endoscopic polypectomy, in a high risk managed care population. Material and method: Cohorts of 77 subjects with benign neoplasms were identified with a colonoscopy in 1999. Three groups of subjects: benign neoplasms with polypectomy, benign neoplasms without polypectomy, and no neoplasms were evaluated. Five years recurrence rates (1999-2004) of benign or new malignant colorectal neoplasms were identified: for the benign determined for the baseline benign neoplasms with polypectomy and no neoplasm groups neoplasm without polypectomy, only rates for malignancy were observed. Malignancy was evaluated with immunohistochemical p53 (tumor protein 53) and PCNA (Proliferating Cell Nuclear Antigen) staining pattern. Over the next 8 years 2004-2012 were evaluated the mortality and the recurrence rate of the benign polyps. Results: 77 subjects were enrolled in our study; 71.4% were diagnosed with benign and 2.5% with malignant neoplasms. The 5-years cumulative incidence rates of malignant colorectal neoplasms in the no neoplasm (n=20) and benign neoplasm groups (n=55) were (n=1) 5% and (n=10) 18.1%, respectively (p < 0.005). A lower 5-years malignancy rate was observed in benign neoplasms group with polypectomy (12%) compared to the benign neoplasm group without polypectomy (33.3%) (p < 0.05). The 8-years mortality rate was compared into benign recurrent polyps group and into malign group: the lower 8-years mortality rate was observed into benign polyp no neoplasm group (0%) and into benign recurrent polyps group (40%); the highest rate was observed into neoplasm group (100%). Conclusions: The high recurrence rate of benign colorectal neoplasms and a higher incidence of colorectal cancer in subjects at high risk-history of benign colorectal neoplasm-highlight a healthcare opportunity for surveillance and/or interventions to reduce the morbidity associated with colorectal neoplasms.

Author Biographies

  • Marilena STOIAN, Carol Davila University of Medicine Bucharest, Romania

    Dr. Ion Cantacuzino Hospital, Bucharest, Romania

  • Emilia RUSU, Carol Davila University of Medicine Bucharest, Romania

    „Prof. Nicolae Paulescu” National Institute of Diabetes, Nutrition and Metabolic Diseases, Bucharest, Romania

  • V. STOICA, Carol Davila University of Medicine Bucharest, Romania

    Dr. Ion Cantacuzino Hospital, Bucharest, Romania

  • R. S. GAVRIL, University of Medicine and Pharmacy ”Grigore T. Popa”- Iasi

    Faculty of Medicine                                                                                                                                                                      Ph.D. student

  • Andreea GHERASIM

    Faculty of Medicine                                                                                                                                                                  Ph.D. student

  • Gabriela RADULIAN, Carol Davila University of Medicine Bucharest, Romania

    „Prof. Nicolae Paulescu” National Institute of Diabetes, Nutrition and Metabolic Diseases, Bucharest, Romania

References

1. Jemal A, Siegel R, Ward E et al. Cancer statistics, CA Cancer J Clin 2008; 58: 71-96.
2. American Cancer Society. Cancer Facts and Figures, Atlanta, Ga: American Cancer Society, 2011.
3. Lieberman DA, Weiss DG, Bond JH et al.Use of colonoscopy to screen asymptomatic adults for colorectal cancer. N Eng J Med 2000; 343: 162-168.
4. Desch, CE, Benson, AE, Smith, TJ et al. Recommended colorectal surveillance guidelines by the American Society of Clinical Oncology. J Clinical Oncol 1999; 17: 1312–1321.
5. Read AP, Strachan T. Human molecular genetics 2. New York: Wiley; Chapter 18: Cancer Genetics, 1999.
6. Unk I, Hajdu I, Fatyol K, Hurwitz J, Yoon J-H, Prakash L, Prakash S, Haracska L.
Proc. Natl. Acad. Sci. U.S.A. 2008; 105: 3768-3773.
7. Winawer SJ, St. John DJ, Bond JH et al. Prevention of colorectal cancer: Guidelines based on new data. WHO Collaborating Center for the Prevention of Colorectal Cancer. Bull World Health Organ 1995; 73: 7–10.
8. Byers T, Levin B, Rothenberger DA et al. American Cancer Society Detection, and Treatment Advisory Group on Colorectal Cancer. American Cancer Society guidelines for screening and surveillance for early detection of colorectal polyps and cancer: Update. CA Cancer J Clin 1997; 47: 154–160.
9. Winawer SJ, Zauber AG, Ho MN et al. Prevention of colorectal cancer by colonoscopic polypectomy. N Eng J Med 1993; 329: 1977-1981.
10. Avidan B, Sonnenberg A, Schnell TG, Leya J, Metz A, Sontag S. New occurrence and recurrence of neoplasms within 5 years of a screening colonoscopy. Am J Gastroenterol 2002; 97: 1524-1259.
11. Winawer SJ, Zauber AG, Fletcher RH et al. Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. Gastroenterol 2006; 130: 1872-85.
12. Rex DK, Cutler CS, Lemmel GT et al. Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies. Gastroenterol 1997; 112: 24-28.
13. Pickhardt PJ, Choi JR, Hwang I et al. Computed tomographic virtual colonoscopy to screen for colo-rectal neoplasia in asymptomatic adults. N Engl J Med 2003; 349: 2191-2200.
14. Atkin W, Rogers P, Cardwell C et al. Wide variation in adenoma detection rates at screening flexible sigmoidoscopy. Gastroenterol 2004; 126: 1247-1256.
15. van Stolk RU, Beck GJ, Baron JA, Haile R, Summers R. Adenoma characteristics at first colonoscopy as predictors of adenoma recurrence and characteristics at follow-up. Gastroenterol 2008; 115: 13-18.
16. Martinez ME, Sampliner R, Marshall JR, Bhattacharyya AK, Reid ME, AlbertsDS. Adenoma charac-teristics as risk factors for recurrence of advanced adenomas.Gastroenterol 2001; 120: 1077-1083.
17. Noshirwani KC, van Stolk RU, Rybicki LA, Beck GJ. Adenoma size and number are predictive of adenoma recurrence: implications for surveillance colonoscopy. Gastrointest Endosc 2000; 51: 433-437.

Additional Files

Published

2018-05-07